SCHEMBL16640338

SCHEMBL16640338

CC(C)n1c2cnccc2c2ccncc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 5/20 0.50
NFATC1 O95644 3/20 0.50
GSK3B P49841 3/20 0.50
USP2 O75604 1/20 0.42
HTT P42858 1/20 0.42
NCOA1 Q15788 1/20 0.42
NCOA3 Q9Y6Q9 1/20 0.42
KCNH2 Q12809 1/20 0.42
CDK4 P11802 2/20 0.40
METAP2 P50579 1/20 0.38
CDK6 Q00534 1/20 0.37
ROCK2 O75116 1/20 0.36
POLB P06746 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2A P29274 1/20 0.36
KDM5A P29375 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR2B P41595 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16640336 0.92 DYRK1A (0.45) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL16640344 0.91 ACHE (0.46) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL2719167 0.83 CHUK (0.42) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL16640345 0.83 USP2 (0.46) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL25467587 0.81 DYRK1A (0.40) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL16640326 0.81 USP2 (0.40) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL16640342 0.81 CDK4 (0.41) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL12464508 0.81 MAOA (0.51) HTTROCK2POLBBCHEACHE
SCHEMBL23380303 0.80 DYRK1A (0.42) DYRK1ANFATC1GSK3BUSP2HTT
SCHEMBL14665591 0.80 NPY5R (0.43) DYRK1ANFATC1GSK3BKCNH2CDK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9947881-B2 Platinum complexes and devices ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY (US) 2018-04-17 US disclosed
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2017-01-12 US disclosed
US-9385329-B2 Platinum complexes and devices Arizona Board of Regents on behalf of Arizona State University and Universal Display Corporation (US) 2016-07-05 US disclosed
US-20150105556-A1 PLATINUM COMPLEXES AND DEVICES ARIZONA BOARD OF REGENTS ON BEHALF OF ARIZONA STATE UNIVERSITY 2015-04-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170012224-A1 PLATINUM COMPLEXES AND DEVICES OXA1L, OCIAD1, OCIAD2 DYRK1A 4759/4885NFATC1 4160/4885GSK3B 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.